The National Comprehensive Cancer Network (NCCN) Oncology Research Program (ORP) announced initiatives for the first time to evaluate a potent and selective inhibitor of the…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.